Our Team

The core 3E team has more than 10 years of healthcare investment experience and industry expertise in pharmaceutical and biotech.

Join Us
← View Team

Howard Schulman

Dr. Howard Schulman is the President and CSO of Allosteros Therapeutics and Executive Advisor at Translational Medicine. 
He was Vice President at PPD Biomarker Discovery Sciences and Vice President of R&D at SurroMed. Prior to his industry career, Dr. Schulman was a Professor at Stanford University School of Medicine.